Search research articles
Contact Us
Filters
Showing results (131-140 of 151) with videos related to
Page
of 16
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2021
Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis
Charles Whittaker, Oliver J Watson, Carlos Alvarez-Moreno, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
JAMA
|
July 6, 2021
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis
, Manu Shankar-Hari, Claire L Vale, et al.
JAMA
|
March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Charlotte A Bradbury, Patrick R Lawler, et al.
Thorax
|
May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Lennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
The New England Journal of Medicine
|
October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19
, Thomas E Hills, Elizabeth Lorenzi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 27, 2026
Intermediate Dose Heparin Thromboprophylaxis among Critically Ill Patients with COVID-19: A Randomised Clinical Trial
, Charlotte A Bradbury, Bryan J McVerry, et al.
JAMA
|
April 11, 2023
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial
, Patrick R Lawler, Lennie P G Derde, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 151) with videos related to
Sort By:
Page
of 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2021
Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis
Charles Whittaker, Oliver J Watson, Carlos Alvarez-Moreno, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
JAMA
|
July 6, 2021
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis
, Manu Shankar-Hari, Claire L Vale, et al.
JAMA
|
March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Charlotte A Bradbury, Patrick R Lawler, et al.
Thorax
|
May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Lennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
The New England Journal of Medicine
|
October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19
, Thomas E Hills, Elizabeth Lorenzi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 27, 2026
Intermediate Dose Heparin Thromboprophylaxis among Critically Ill Patients with COVID-19: A Randomised Clinical Trial
, Charlotte A Bradbury, Bryan J McVerry, et al.
JAMA
|
April 11, 2023
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial
, Patrick R Lawler, Lennie P G Derde, et al.
Page
of 16